Profil

Mr. Kyle M.
Lauzon
is a Director-Institutional Sales Group at C.
K.
Cooper & Co. He joined C.
K.
Cooper & Co. in October 2009.
He has 18 years experience in the financial services sector and for the last 10 years has been exclusively focused on institutional research sales in the healthcare and technology sectors.
Most recently, he was a Managing Director of Institutional Equity Sales at Biologic Investment Research, LLC.
Prior to joining Biologic Investment Research, LLC, Mr. Lauzon was the Director of Institutional Equity Sales for Dawson James Securities.
At Dawson James, he was responsible for building out the institutional equities distribution and trading platforms.
Mr. Lauzon also developed and managed regular expert led conference calls, surveys as well as both deal and non-deal corporate road shows.
Mr. Lauzon received multiple awards while at Dawson James in 2006 & 2007 for top institutional production.
In late 2001, Mr. Lauzon joined Sterling Financial Investment Group as an institutional sales representative where by the end of 2002 he had become the desk's top producer and was awarded "MVP" status for his exceptional performance.He holds series 7, 24, and 63 securities licenses.

Ehemalige bekannte Positionen von Kyle M. Lauzon

UnternehmenPositionEnde
Institutionelle Verkäufe 01.11.2010
Trading-Equity 30.09.2009
Institutionelle Verkäufe 31.12.2008
Institutionelle Verkäufe -
Sehen Sie sich die Erfahrung von Kyle M. Lauzon im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Kyle M. Lauzon im Detail an

Beziehungen

11

Beziehungen ersten Grades

4

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen4

Finance

Finance

Finance

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Kyle M. Lauzon